Whole-genome sequence (WGS) data can, in principle, resolve bacterial isolates that differ by a single base pair, thus providing the highest level of discriminatory power for epidemiologic subtyping. Nonetheless, because the capability to perform whole-genome sequencing in the context of epidemiological investigations involving priority pathogens has only recently become practical, fewer isolates have WGS data available relative to traditional subtyping methods. It will be important to link these WGS data to data in traditional typing databases such as PulseNet and PubMLST in order to place them into proper historical and epidemiological context, thus enhancing investigative capabilities in response to public health events. We present MIST (Microbial In Silico Typer), a bioinformatics tool for rapidly generating in silico typing data (e.g. MLST, MLVA) from draft bacterial genome assemblies. MIST is highly customizable, allowing the analysis of existing typing methods along with novel typing schemes. Rapid in silico typing provides a link between historical typing data and WGS data, while also providing a framework for the assessment of molecular typing methods based on WGS analysis.
INTRODUCTION
A key component of the public health response to priority pathogens involves efforts to implement broadbased systems for epidemiologic surveillance. These activities are aimed at examining geographical/host distribution and sources of disease, with the ultimate goal of reducing the burden of illness through targeted interventions that disrupt pathogen transmission pathways.
The last two decades have witnessed the emergence of DNA-based subtyping methods, which have become integral to epidemiology, making it one the most powerful tools in public health (van Belkum, 2003) . Genotyping methods have revolutionized the field of epidemiology by enhancing the ability to discriminate between isolates, which has made it invaluable in a range of contexts: early outbreak detection; microbial source attribution to determine sources of contamination and exposure; identification of the types and subtypes of pathogenic bacteria circulating among humans, animals, and the environment (Foxman and Riley, 2001) . Various subtyping schemes have been developed based on the analysis of different types of polymorphisms that can be broadly classified into three major groups: DNA banding-pattern based methods, such as pulsed-field gel electrophoresis (PFGE) and restriction fragment length polymorphism (RFLP); DNA hybridization-based methods, such as PCR and microarrays; and DNA sequencebased methods, such as multilocus sequence typing (MLST) (Li et al., 2009) . Although these methods have been applied with varying levels of success, the increasing resolution of modern methods has greatly enhanced epidemiologic investigations. For example, by identifying cases with matching subtyping data, it has been possible to distinguish outbreak cases from concurrent sporadic cases (Singh et al., 2006) .
While a few leading techniques remain widely used tools for strain characterization, high-throughput whole-genome sequencing (WGS) has rapidly become a viable option for the investigation of priority pathogens in the context of public health events (Gilmour et al., 2010; Alexander et al., 2012) . In principle, WGS data can resolve bacterial isolates that differ by a single base pair, providing the highest level of discrimination for bacterial strain characterization. However, because the capability to perform WGS for subtyping has only recently become practical, relatively few isolates have WGS data available compared to traditional typing methods such as PFGE or MLST, which have dedicated databases with extensive historical data going back a decade or more. Thus, a critical component in the transition from molecular epidemiology based on existing genotyping approaches to a genomic epidemiology paradigm based on the analysis of WGS data in an epidemiologic framework will be the linkage of WGS data to databases such as PulseNet (Swaminathan et al., 2001) and PubMLST (Jolley et al., 2004) . This will allow genomic data to be placed into proper historical and epidemiological context, thus enhancing the analysis of surveillance data and the investigation of outbreak data.
This study presents Microbial In Silico Typer (MIST), a tool for the rapid in silico generation of molecular typing profiles (e.g. MLST, MLVA) from draft bacterial genome sequences. We have recently reported results obtained using MIST as part of a framework for assessing the performance of existing molecular typing methods for Campylobacter jejuni and C. coli using WGS data (Carrillo et al., 2012) . In this study we present the full implementation of MIST and demonstrate the utility of MIST analysis using finished, closed and draft assembly genome sequence data from priority human pathogens, and show through comparison with published and experimental data that MIST produces accurate in silico-derived molecular subtyping data for a variety of existing and novel typing approaches. of MIST is currently only supported under Windows (XP, Vista, 7). However, a command-line version of MIST is available for both Windows and Linux. MIST is a freely available application licensed under the GNU General Public License. The application, source code and documentation is available at https://bitbucket.org/peterk87/microbialinsilicotyper and https://bitbucket.org/peterk87/mist for the GUI and command-line versions of MIST, respectively.
IMPLEMENTATION
All analyses performed within MIST utilize sequence similarity searching, which is performed using blastn from the NCBI BLAST+ application suite (Altschul et al., 1990; Camacho et al., 2009) . MIST can produce in silico data for PCR-, probe hybridization-, sequence-, variable number of tandem repeat-(VNTR), and SNP-based typing assays (Figure 1) while also providing users with detailed summary data underlying the subtyping results.
MIST was designed such that the user is free to use existing typing schemes or to create their own. Novel schemes can be based on conventional subtyping approaches or can incorporate molecular targets that would be impractical in the context of a laboratory-based assay. For a given bacterial species, an existing Package, consisting of one or more typing schemes or Assays, themselves comprised of one or more Markers, can be loaded and executed in MIST, yielding in silico results for the assays selected. An assay creation module allows the user to easily edit or create new packages and assays through an entry form or through the import of a tab-delimited file with the necessary assay parameters.
MIST allows the user to easily export typing results or to save and continue an analysis with additional WGS data or typing schemes. MIST simulates in silico PCR using BLAST sequence similarity searching (Figure 2 ). BLAST searches are conducted to find all potential forward and reverse primer binding sites in the subject genome. All combinations of potential forward and reverse primer sites are investigated to determine putative amplicons. A positive result is reported when an amplicon can be retrieved within the expected size tolerances and in which the amplicon is flanked by the forward and reverse primers in either correct orientation. If all primer binding site combinations have been exhausted and no suitable amplicon is generated, a negative result is reported. Although traditional in vitro PCR assays produce only a binary signal, MIST provides a more in-depth analysis of PCR results. A summary of binary absence-presence results along with detailed match information can be accessed for each PCR marker match.
PCR-based Typing

VNTR-based Typing
MIST simulates in silico VNTR results (i.e. MLVA) by using a variation on in silico PCR analysis (Figure 2) . If an amplicon can be retrieved with a length less than the user-defined maximum amplicon size threshold (3000 bp by default), the copy number or the number of repeats is reported. If a suitable amplicon cannot be found, a null result is returned. Although the copy number reported is typically zero or an integer, in the case of partial repeats a non-integer number may be reported. To aid in the intrepretation of the data, detailed match information, such as the most likely primer binding sites and predicted amplicon, is made available. Two modes for in silico probe hybridization analysis are available in MIST. 'Mode 1', which is the default setting, is for 'short' probes (i.e. < 70 bp or user-defined), such as those which might be found on oligonucleotide-based microarrays. 'Mode 2' is for 'long' probes (i.e. > 70 bp or user-defined), such as those which might be found in amplicon-based microarrays. For 'short' probes the hybridization profile for a genome is predicted using BLAST based on a user-defined percent identity threshold (IDT) for each probe in the assay. For 'long' probes, an alignment length threshold (ALT) is used in addition to the IDT.
Probe Hybridization-based Typing
In both modes, BLAST is used to identify hits for each probe; the hit with highest bit score is used if multiple BLAST hits can be identified. In Mode 1, a positive hit is reported if the top BLAST hit has a percent identity equal to or greater than the IDT over the entire length of the probe. If no BLAST hits can be identified or if the top hit does not fulfill the IDT criterion, a negative result is reported. In Mode 2, a positive hit is reported if the top BLAST hit has a percent identity and alignment length equal to or greater than the IDT and ALT, respectively. If no BLAST hits can be identified or if the top hit does not fulfill the IDT and ALT criteria, a negative result is reported. In addition to the binary absence-presence results MIST provides detailed match information, which is also provided for negative results, thus allowing the user to verify results obtained.
SNP-based Typing
SNP loci can be interrogated using a variation of the in silico probe hybridization (Figure 3 ). To design a SNP-based assay, the SNP position is indicated by an 'N' within a probe sequence. Probe sequences are queried against the subject genome using BLAST. The nucleotide at a SNP position is reported if a match above the IDT can be found in the subject genome. Other match information made available includes the probe match sequence and the location within the subject genome. If a match above the IDT cannot be found within the subject genome, the top BLAST hit is provided along with the number of mismatches with respect to the query probe sequence. The allelic profile of a genome for a given gene marker is determined through sequence similarity searching of a database of the known alleles for the gene using BLAST (Figure 4 ). MIST utilizes a rapid search strategy wherein one allele of each unique size for each allele database is queried against the subject genome. A simple matching algorithm is then used to find a perfect match in the allelic database. If a perfect match cannot be found using this approach, complete pairwise BLAST searching against the allele database is performed to determine the closest matching alleles (i.e. the alleles with least number of mismatches) along with the number of SNPs with respect to the subject genome's allele.
Sequence-based Typing
In addition to the individual allelic profiles, MIST automatically determines the overall sequence type (ST) and clonal complex (CC). If additional metadata is linked to allelic profiles, this ancillary data can be displayed along with ST and CC information.
RESULTS AND DISCUSSION
Wherever possible, MIST-derived typing results were validated by comparison against experimentallyderived typing results obtained from the literature. The accuracy of MIST is inherently linked to the quality of the WGS sequence data (i.e. the subject genome) used as an input because genome assemblies with large numbers of contigs, or regions of poor or absent sequence data may introduce false negatives to the in silico results (Carrillo et al., 2012) . Similarly, accuracy can be impacted by the error rate in experimental data, which is largely due the inherent noise in hybridization, a process upon which most subtyping methods rely. Nevertheless, MIST was found to generate sensitive analyses and in silico results that were highly concordant with experimental data whether from completed whole genome data or from minimally processed draft genome assemblies.
PCR-based Typing: Campylobacter jejuni CGF40 Assay
The comparative genomic fingerprinting (CGF) assay, CGF40 , was used to assess the performance of in silico PCR analysis using MIST. The CGF40 assay targets 40 accessory genes present within C. jejuni NCTC 11168 and variably present in other C. jejuni and C. coli strains. The 40 primer pairs along with the expected amplicon sizes and an amplicon size tolerance of 5% were input into MIST as an Assay.
Based on MIST CGF40 analysis of 25 sequenced C. jejuni genomes, the average concordance between in silico and in vitro-derived results was found to be 92.8% (928/1000 matches) using a blastn word size of 8. The false negative and false positive rates were 4.0% and 3.2%, respectively. Generally, false negative results were attributable to sequence truncations within incomplete draft assemblies. False positive results were largely "true" amplicons that contained SNPs within priming sites, which would likely affect amplification under standard PCR conditions. For example, marker cj1721 yielded a concordance of only 48%, with 13 false positive discrepancies. A multiple sequence alignment of the retrieved cj1721 amplicons revealed several SNPs in both priming sites. However, after reducing the stringency of the test by increasing the blastn word size, the false positive rate for cj1721 dropped from 48% to 12% without appreciably changing the overall concordance of the remaining markers in the assay.
Thus, the blastn word size can be used to adjust the stringency of an in silico PCR test. A larger word size (e.g. >7) will produce results that are highly specific (and less sensitive) with respect to the given primer inputs; likely producing results that are more concordant with in vitro PCR due to fewer false positive matches. Alternatively, a lower word size (e.g. <7) will produce results that are more sensitive (and less specific), which may be useful for exploratory analyses where multiple sequence alignments of the retrieved amplicons can be investigated to further examine differences between strains.
MIST offers user control over the in silico results and provides a variety of output data making it a valuable tool in the validation and creation of novel PCR typing schemes.
VNTR-based Typing:
Listeria monocytogenes MLVA VNTR typing was simulated using an MLVA scheme for L. monocytogenes (Miya et al., 2008) on 23 publicly available L. monocytogenes genomes. In silico VNTR data generated by MIST are shown in Table 1 . The in silico VNTR results for F2365 matched the expected results with 14, 17 and 9 repeats in the VNTR loci TR1, TR2 and TR3, respectively. It was not possible to validate results obtained by MIST in any L. monocytogenes strains other than F2365 because of the lack of available MLVA data on genome-sequenced strains in the literature for this or other MLVA schemes. MIST was unable to find an amplicon in some cases for the MLVA marker TR1. This is consistent with previous observations on the potential unsuitability of the TR1 locus due to variability between strains in that region (Miya et al., 2008) . Our results thus illustrate how MIST may be a valuable tool in the in silico validation and development of novel VNTR-based typing schemes.
Probe Hybridization-based Typing:
Escherichia coli Pathotyping Microarray
Probe hybridization was simulated using the probe sequences from the E. coli miniaturized pathotyping microarray (Anjum et al., 2007) on 110 E. coli genomes obtained from NCBI. The microarray consists of a combination of 61 probes targeting virulence, bacteriocin and conserved genes that are shared among or specific to E. coli pathotypes. Concordance was calculated between the in silico and in vitro array for the seven E. coli strains shared between the public and study datasets. The overall concordance for these seven E. coli II  35  12  9  08-5578  II  35  12  9  HCC23  III  -22  5  L99-4a  III  -22  5  M7  III  -22  5  J2-071  III  -16  5 strains was 93.4% (399/427 matches) using a probe percent identity threshold of 90%. The false negative and false positive rates were 2.8% and 3.8%, respectively. The rrl 23S rRNA control gene probes accounted for the majority of discrepancies (71.4%), since four probes from this locus had mismatches in more than half of the strains tested. Removal of the rrl control gene probes increased the concordance to 97.9% (322/329 matches). Generally, false negative results by MIST were attributable to SNPs within the probe hybridization site resulting in a %ID below the 90% ID threshold. False positive results by MIST were confirmed to be full length or near full length matches with greater than 95%ID (0-2 mismatches). In silico pathotype designations are shown in Table 2 . 
SNP-based Typing: Listeria monocytogenes TMLGT
An in silico SNP-based typing assay was created based on the targeted multilocus genotyping assay (TMLGT) for L. monocytogenes (Ward et al., 2010) . The 30 probe assay simultaneously classifies the 4 lineages, 4 major serotypes and four epidemic clones (EC) of L. monocytogenes by interrogating a 3' SNP diagnostic for one of the aforementioned groups. The MIST assay for TMLGT was tested against 23 publicly available L. monocytogenes genome sequences and validated by comparing known lineage, serotype and EC designations to the MIST-derived designations. MIST results for the TMLGT assay placed all 23 strains into their correct lineages. Serotypes were correctly assigned to 15 out of 17 strains belonging to one of the four serotypes targeted by this assay. All eight strains belonging to known EC groups were correctly identified (Table 3) . SNP-based typing assays are particularly amenable to analysis in MIST because the results require little analytical interpretation, as a SNP variant determination is directly linked to the underlying sequence data. Furthermore, because the assay is performed in silico, literally any number of variant sites can be tested for, allowing for the development and testing of assays consisting of hundreds if not thousands of markers, which would be difficult to deploy in a laboratory setting.
Sequence-based Typing:
Staphylococcus aureus MLST Sequence-based typing was simulated using the MLST scheme for Staphylococcus aureus (Enright et al., 2000) . Genome sequences for 63 publicly available S. aureus strains for which corresponding STs were available from the MLST database (saureus.mlst.net) were examined. The concordance, calculated by computing the number of matching alleles between in vitro and in silico MLST data as a proportion of the total number of alleles, was found to be 98.6% (435/441 matching alleles). Six allelic discrepancies were found among five genomes, and were investigated using the detailed match information available within MIST. Five discrepancies were cases in which a different allele number was assigned based on a minor SNP variant; four cases differed by a single SNP, and one case differed by two SNPs. In each case, results obtained with MIST reflected a canonical match between the underlying WGS data provided and the discordant allele in the database. For the remaining case of allelic -HCC23  III  --L99-4a  III  --M7  III  --J2-071 III --discrepancy, the allele for arcC in genome TCH60 could not be identified. Further examination revealed a single-base adenine deletion within a 7-base polyadenine tract; an error common in 454 pyrosequencing. After correcting for this assumed error, the TCH60 arcC allele was correctly assigned by MIST as arcC 2. These data not only show that MIST can accurately determine MLST data with a very high degree of confidence, but also illustrate how the detailed information provided by MIST can prove useful. The MIST platform could be used in the testing and development of expanded MLST schemes including whole-genome MLST analysis, which are of great interest in the context of rapid whole genome-based subtyping of strains. Moreover, the provision of additional subtype-associated metadata is a feature not common among other in silico MLST tools, including those provided by online MLST databases.
quencing of more than one or a small number of strains for a particular species.
Ultimately, high quality, whole genome sequencing is the true gold standard for molecular characterization of microbes. In addition to encoding all of the information necessary to determine conventional molecular typing profiles, WGS provides the most comprehensive data for inferring strain to strain phylogenetic relationships. For these reasons, WGS analysis has become increasingly prominent in the public health response to pathogens, enabling characterization of organisms at an unprecedented level of resolution. Moreover, as the cost of sequencing continues to decline, the applicability of WGS will broaden to a larger scope of strains and, in the near future, will likely become the method of choice for characterization of all microbes.
In the context of public health, a significant gap currently exists in that although WGS analysis has been shown to be viable in the context of public health events such as outbreaks (Gilmour et al., 2010) , it may not yet be possible to perform WGS in the context of routine epidemiologic surveillance. In silico typing provides the opportunity for the utilization of WGS data as a framework for comparing the performance of existing molecular typing methods or for assessing and validating novel methods (Carrillo et al., 2012) .
Moreover, while ever-expanding, WGS datasets still comprise only a fraction of the historical data contained in public repositories of molecular typing data, such as PulseNet (Swaminathan et al., 2001) and PubMLST (Jolley et al., 2004) , and this is not likely to change in the immediate future. Establishing links between WGS data and the data contained in molecular epidemiology databases will be critical as we transition from a paradigm involving molecular typing to one that is based on WGS.
Recently developed comparative genomics-based tools have been developed with the aforementioned goals in mind. A web-based tool was recently developed for in silico MLST analysis of bacterial isolates using WGS data (Larsen et al., 2012) . Bacterial Isolate Genomic Sequence Database (BIGSDB), which is based on the mlstdbNet platform (Jolley et al., 2004) , has been developed for storage and analysis of WGS data along with other types of data such as MLST data (Jolley and Maiden, 2010) . BIGSDB has been used in conjunction with Ion Torrent sequencing to rapidly generate accurate typing data on multiple methods for Neisseria meningitidis (Vogel et al., 2012) . MIST was designed to provide a complimentary approach to existing tools by allowing users the flexibility to analyze draft WGS data and produce in silico typing profiles for traditional typing schemes, assays based on modifications on these traditional schemes, and assays based on novel typing schemes.
In silico typing profiles can be linked to historical typing data from public databases and to other available metadata on each genome analysed, such as phenotypic, clinical, or epidemiological information, enabling the user to examine associations between the sub-typing data and their underlying metadata. Since MIST allows the user to design and test schemes based on approaches that may be impractical to perform in vitro, extended MLST schemes or hybridization-based methods targeting hundreds of loci can be tested that would otherwise be subject to sensitivity/specificity issues when deployed in the lab. Furthermore, the MIST platform enables comparison between typing methods through the simultaneous generation of in silico typing results for a variety of different methods.
As we move into the era of broad-based WGS, it is important to consider the relationship between WGS data and historical molecular typing databases, which are rich sources of molecular and epidemiological information. Ideally, these sources of information should be used cooperatively; large molecular epidemiological databases should be used as resources for targeted selection of strains for WGS projects, and the corollary, as WGS begins to replace to traditional genotyping, the ability to rapidly assess relevant genetic markers from an abundance of minimally processed sequence data will become an essential requirement towards leveraging these data for maximum public health impact. Continued efforts toward the development of bioinformatics tools that enable rapid analysis of draft genome data will enable public health laboratories to not only link WGS data to historical data but provide a framework for use in the development of novel analytical methods and provide an improved understanding of the performance of current methods to assist in the interpretation of existing studies.
